Skip to main content
ENTA
NASDAQ Life Sciences

Enanta Posts 81-Cent Quarterly Loss as Patent Setback Clouds Pipeline

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$10.66
Mkt Cap
$312.224M
52W Low
$10.05
52W High
$17.15
52W Position info
6.1% above low
Off High info
38% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

ENTA is trading near its 52-week low of $10.05 (6.1% above the low).

Summary

Enanta reported a fourth-quarter loss of 81 cents per share, with a 4Q loss of $23.7M on revenue of $12.9M. That follows a Q3 net loss of $19.5M disclosed in the August 10-Q, so the company remains unprofitable while funding its RSV and immunology programs, and it reported an FY2026 net loss of $68.2M. The loss lands two weeks after the EU Unified Patent Court invalidated its '265 patent and dismissed its infringement action against Pfizer, removing a key legal lever. With a $75M at-the-market program already in place and a $150M shelf on file, dilution risk stays live for a company of this size.

At the time of this announcement, ENTA was trading at $10.66 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $312.2M. The 52-week trading range was $10.05 to $17.15. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

ENTA - Latest Insights

ENTA
Nov 16, 2026, 4:10 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $10.41
Real-time Price: $11.20 info
Change: +$0.790 (+8%) info
Market Cap: $310.768M info
ENTA
Oct 29, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $11.15
Real-time Price: $11.20 info
Change: +$0.050 (+0.45%) info
Market Cap: $310.768M info
ENTA
Oct 28, 2026, 7:14 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $11.99
Real-time Price: $11.20 info
Change: -$0.790 (-7%) info
Market Cap: $310.768M info
ENTA
Aug 12, 2026, 7:00 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $13.52
Real-time Price: $11.20 info
Change: -$2.32 (-17%) info
Market Cap: $310.768M info
ENTA
Aug 10, 2026, 4:01 PM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $13.81
Real-time Price: $11.20 info
Change: -$2.61 (-19%) info
Market Cap: $310.768M info